Abstract
Hexavalent chromium (salt) is a form of chromium responsible for sensitization and contact dermatitis in chromate allergy.
Exposure to chromium is often occupational and is commonly seen among building workers handling cement, leather workers, electroplaters, welders, and painters.
Addition of ferrous sulfate has reduced the incidence of chromate allergy in the Scandinavian countries, since it decreases the concentration of hexavalent chromate in cement.
Simple office-based tests are helpful in detecting chromium in objects.
Patch testing with chromate (in chromium-sensitive subjects) to detect the minimum elicitation threshold (MET) is best done by using serial dilutions of Cr(III) and Cr(VI).
Chromium can cause lipid peroxidation, nephrotoxicity and affect the immune system.
Reduction or elimination of exposure is the best method of prevention of chromium-induced contact allergy.
Access provided by Autonomous University of Puebla. Download reference work entry PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
FormalPara Core Messages-
Hexavalent chromium (salt) is a form of chromium responsible for sensitization and contact dermatitis in chromate allergy.
-
Exposure to chromium is often occupational and is commonly seen among building workers handling cement, leather workers, electroplaters, welders, and painters.
-
Addition of ferrous sulfate has reduced the incidence of chromate allergy in the Scandinavian countries, since it decreases the concentration of hexavalent chromate in cement.
-
Simple office-based tests are helpful in detecting chromium in objects.
-
Patch testing with chromate (in chromium-sensitive subjects) to detect the minimum elicitation threshold (MET) is best done by using serial dilutions of Cr(III) and Cr(VI).
-
Chromium can cause lipid peroxidation, nephrotoxicity and affect the immune system.
-
Reduction or elimination of exposure is the best method of prevention of chromium-induced contact allergy.
1 Introduction
Chromium is a metallic element that is commonly found in the environment. Cement was one of the earliest agents incriminated in the causation of chromate dermatitis, with a high incidence among construction workers (handling wet cement). Exposure to chromium may be occupational or household with the skin and mucus membranes both being affected. The risk of exposure to chromium is high among other industries/professions such as leather tanning, chrome plating, welding, carpentry (handling of chromated metal products – screws and fittings), painting (also water coolants), and printing. In susceptible individuals, bleaches and detergents and stainless steel utensils containing chromium may also be potential causes of chromate sensitization.
Chromium is derived from the Greek word chroma meaning color due to the brightness of many of its salts. It can occur in every one of the oxidation states from −2 to +6, but the ground states 0, +2, +3, and +6 are common (Love 1983). The metal chromium in itself does not act as an allergen, but does so, in combination with a protein. Only the trivalent and hexavalent salts are able to act as haptens and form potentially antigenic bonds with proteins. It is highly resistant to corrosion in the atmosphere and many aqueous solutions, and is an unlikely cause of contact allergy.
2 Toxicity
While trivalent chromate is not considered toxic, hexavalent chromate has significant toxic effects. In sufficient concentrations it can cause respiratory symptoms such as bronchitis (Langard 1983) and asthma (Fernandez-Nieto et al. 2006), irritant dermatitis and chrome ulcers of the skin and mucous membranes, affect the immune system (Snyder et al. 1996) and also induce cancer, particularly of the lung (Bidstrup 1983).
Its effects on the immune system are demonstrated by the significantly lower levels of IL-6 in workers exposed to chromium, as compared to the normal population (Snyder et al. 1996). However, it was found that exposure to Cr(VI) in early stages can stimulate IL-6 and IL-8 and cause a fall in the percentage of B-cells (Kuo and Wu 2002).
2.1 Chrome Ulcers
The commonest symptoms associated with the irritant effect of chromates are chrome ulcers/holes occurring either on the skin (cement workers) or nasal septum (electroplaters and lithographers). The ulcers occur as 2–5 mm punched out lesions that heal with scarring, when the patient is removed from the source. Necrosis of cartilage (but not bone) can ensue but malignant change does not occur (Williams 1997).
In 1978, there were about 100 reported cases of chrome ulcers occurring in the UK (Burrows 1978).
The ulcer is formed due to the toxic necrotizing action of chromium on tissue. A recent report demonstrated that Cr(VI) causes mitochondrial-dependent apoptosis of the dermal fibroblasts by disrupting their actin cytoskeleton (Rudolf et al. 2005), contributing to the formation of an ulcer. In addition, workers prone to ulcer formation seem to have a lower incidence of allergic contact dermatitis (Walsh 1953). This is probably because the ulcer impairs the ability of the skin to mount an immune response.
An active program of reducing chromate contamination at workplaces can significantly reduce the incidence of chrome ulcers (Dornan 1981; Williams 1997).
3 Contact Dermatitis
3.1 Irritant Contact Dermatitis
Irritant dermatitis is seen particularly in workers exposed to chrome, where the exposure to chromium is high.
3.2 Allergic Contact Dermatitis
Dermatitis occurs more commonly with Cr(VI) than Cr(III) chromate. Cr(III) binds very readily to protein, and thus penetrates the skin poorly; little trivalent chromate gets past the stratum corneum. On the other hand, Cr(VI) penetrates easily and deeply into the dermis where it is transformed to Cr(III), which results in the formation of hapten-protein complex capable of being processed as an allergen. Guinea pig sensitization with Cr(III) is difficult; however, once sensitized, they react to patch testing in a similar fashion to those sensitized with Cr(VI) (Polak 1983).
3.3 Patch Testing
The standard test material is potassium dichromate in petrolatum (0.5%, Europe; 0.25%, USA). At these concentrations contact allergy can be elicited, besides being close to the concentration at which irritant reactions can occur (Burrows 1987). Patch testing with 0.5% and 0.375% potassium dichromate will produce a number of irritant reactions, whereas patch testing with lower percentages, while producing fewer irritant reactions, will miss some allergic reactions (Burrows et al. 1989). Consequently, 0.25% is probably a safer percentage in the hands of those lacking experience in patch testing.
A population-based, serial dilutions patch testing method (Fig. 44.1 ), demonstrating the wide range in patient/worker sensitivity has been published (Nethercott et al. 1994). This method implements the delivery of a controlled amount of allergen per surface area of skin, for determination of the minimum elicitation threshold (MET). The high water solubility of compounds K2Cr2O7 [Cr(VI)] and CrCl3 [Cr(III)] is exploited for their application as T.R.U.E. test patches. The serial dilutions of Cr(III) and Cr(VI) used are given in Table 44.1 .
4 Incidence of Chromate Allergy
The incidence of positive patch tests to chromate depends on the subset of workers being studied and illustrates the risk of getting sensitized. In a study of healthy volunteers, the patch test positivity to chromium was 0.5% in those without apparent contact with chromate, as compared to 1.8% in those who had contacted chromate (Peltonen and Fraki 1983). A similar incidence of 1.7% in chromate-pigment workers (Decaestecker et al. 1990), and 2.9% in prefabrication-construction factory workers (Goh et al. 1986b) with normal skin, has been noted. In a review of world literature, the incidence of chromate sensitivity in a routine patch testing clinic was found to be 7.9% (Nethercott 1982). Patch test positivity to dichromate was noted in 6.8% of 1,159 men and 2.8% of 1,823 women, elsewhere (Peltonen and Fraki 1983). Of these, 16.1% of the men and 18.1% of the women had a present or past history of atopic dermatitis; however of the 390 patients with atopic dermatitis as a primary diagnosis, only 1.3% showed a positive reaction to dichromate. These high figures of apparent allergy to dichromate must be accepted with a certain amount of reserve, bearing in mind the potentially irritant nature of 0.5% potassium dichromate, which could give irritant reactions in those with active skin disease. Indeed, Fischer and Rystedt (1985) found that only 40% of their positive chromium patch tests were relevant.
In a skin clinic, the incidence of chromate sensitivity is close to 1–2% and, if the figures are higher, then some special reason should be sought. The data from two British occupational surveillance schemes found 22,184 cases of occupational contact dermatitis over a period of 11 years (1993–2004), of which chromium accounted for 6% of the cases with a male:female ratio of 5:1(Athavale et al. 2007). The Finnish register of occupational diseases observed a 5.6% incidence of ACD due to chromium over a 7 year period (1991–1997). The incidence of chromium allergy per 10,000 working years in different occupations has also been elaborated in Table 44.2 (Kanerva et al. 2000).
The prevalence of chromate allergy in Denmark decreased significantly from 3.6% (in 1985) to 1% (in 1995), and then increased again to 3.3% in 2007 (Thyssen et al. 2009).
5 Exposure to Chromium
Contact exposure is possible with the following compounds (Burrows and Adams 1990):
-
Metals
-
Analytic standards/reagents
-
Anticorrosion agents
-
Batteries
-
Catalysts (for hydrogenation, oxidation, polymerization)
-
Ceramics
-
Cement
-
Drilling muds
-
Chromium lignosulfonates (from sodium dichromate using lignosulfate waste)
-
Electroplating, anodizing agents
-
Engraving
-
Explosives
-
Fire retardant
-
Galvanized sheeting
-
Hardeners, resins (aircraft industry)
-
Leather
-
Magnetic tapes
-
Metallic chromium
-
Milk preservatives
-
Paints and varnishes
-
Paper
-
Chrome cake (sodium sulfate/dichromate)
-
Photography
-
Roofing
-
Stainless steel
-
Sutures
-
Tanning leather
-
Textile mordants and dyes
-
Television screens
-
Welding
-
Wood preservatives
Chromium is used in the industry as follows:
-
1.
Metallurgical industries (85%): primarily stainless steel. It is added to harden the metal and provide high-temperature strength and corrosion resistance. It is also used in combination with aluminum, zirconium, and zinc alloys.
-
2.
Chemical applications (8%): predominantly used in leather tanning followed by timber preservation and in paints, inks, textiles, and as pigments in plastics. Zinc and strontium chromates are used as corrosion inhibitors in priming paints. Chromium is used as a catalyst in drilling muds, water treatment, electroplating, passivation treatments of metal, and as a preservative in milk testing.
-
3.
Refractory bricks (7%): useful in refractory linings for furnaces and the kilns of the cement industry, and in molding sands in foundries because of its high melting point and relatively low cost.
5.1 Cement
Cement, of course, is by far the most common and best-recognized cause of chromate allergy. Cement contains varying amounts of chromate; for instance, it was found that the chromate content of water-soluble cement in Australia varied from less than 1 ppm to 124 ppm, with the majority tested showing less than 10 ppm (Ellis and Freeman 1986). Cement, upon addition of water, becomes alkaline (pH,12) and is probably a factor in facilitating sensitization to the chromate in cement. This probably explains the rarity of allergic contact dermatitis to chromate in cement-manufacturing workers or in those handling dry, powdered cement. The percentage of patients with cement dermatitis who have positive patch tests to chromate is probably 80–85%, but some (Conde-Salazar et al. 1995) have found lower levels (42%; 20% had positive patch tests to cobalt). Chromate in cement derives from the ingredients (clinker), the machinery used in processing (grinders, etc.), and from refractory bricks. Most of the chromate that goes into the cement is trivalent, but a varying proportion of this is changed to hexavalent chromate during manufacture.
This is important, because in future it is likely that the amount of chromate in cement will decrease due to the following factors: (1) a number of magnesium chrome refractories are currently beginning to use magnesium aluminate (spinal refractories) (Tandon and Aarts 1993); (2) slag from iron blast furnaces, which contains little or no chromate (Goh and Gan 1996), is likely to be increasingly used as a clinker substance; (3) with increased mechanization, cement is being decreasingly handled, leading to a reduction in cement dermatitis (see Chap. 48, “Cement”); and (4) addition of ferrous sulfate to cement (originally reported by Fregert et al.) decreases the concentration of hexavalent chromate in cement (Fregert et al. 1979). This has been substantiated by the findings of significant decreases in the urinary chromium of workers with hand dermatitis after the addition of ferrous sulfate in cement (Chou et al. 2008), and chromium allergy due to cement from 12.7% in 1989–1994 to 3% in 1995–2007 (Thyssen et al. 2009).
5.2 Anticorrosion Agents
Chromates are still being exploited as anticorrosion agents in water-cooling systems and paints. Their use persists despite their toxicity, as they are very effective, persistent, relatively inexpensive agents, and moreover, they do not form insoluble complexes as some other anticorrosion agents do.
5.3 Welding
Chromium may be present in electrorods used in electric arc welding, together with the metals which are being welded. During welding, chromium is oxidized to hexavalent chrome (present in fumes), which causes dermatitis (Fregert and Ovrum 1963; Shelley 1964).
5.4 Leather
The incidence of chromate allergy in footwear dermatitis varies in different studies. Trivalent chromate is used; hence, the sensitization potential is low. Nevertheless, chromate allergy should always be considered in shoe dermatitis, and possibly even as a factor in hand dermatitis due to wearing of leather gloves. Chromate is used in leather tanning, as a water-repellent [Cr(III) stearate chloride], stain-repellent [Cr(III) and fluorinated carboxylic acids], and as a dye. In those carrying out tanning, the sensitization risk is increased because of contact with other irritants, oxidation of small amounts of Cr(III) to Cr(VI) (Hansen et al. 2002) and wetness in the process of tanning. In Denmark, 35% of leather products had Cr(VI) content exceeding the detection limits of 3 ppm (Hansen et al. 2002), and an increase in the prevalence of chromate allergy due to leather exposure from 24.1% during 1989–1994 to 45% during 1995–2007, (p < 0.02) has been noted (Thyssen et al. 2009), further proving the role of chromate in leather allergy. The histocompatibility antigens (HLA-B8 and DR-3 alleles) have been incriminated in the susceptibility of patients to immunotoxicity with Cr(VI) (Mignini et al. 2004).
5.5 Chrome Plating
Chrome plating, in which chromic acid and sulfuric acid are used, provides a significant risk for exposure to chromate (Lee and Goh 1988).
5.6 Galvanizing
Galvanizing iron with zinc, either by electroplating or dipping in molten zinc, protects it from rusting. Coating with chromate enhances the protective effect. However, this has led to its recognition as a cause of dermatitis to chromate (Rycroft and Calnan 1977).
5.7 Pigments
Chromates are used as:
-
1.
Dye substances (e.g., lead chromate): They are used in an insoluble hexavalent form and, thus, not relevant as a skin hazard. Chromium oxide, a trivalent form, is used in artists’ paints and ceramics.
-
2.
Soluble sodium dichromate: Used as a chelating agent in the presence of acid to yield an insoluble dyestuff. This is particularly used in wool processing.
-
3.
Dyestuffs: This occasional addition prevents wool from reducing the dye.
5.8 Printing
Printing was a relatively common source of allergy to chromate (Burrows 1983); however, with the use of acrylates, this has become infrequent.
5.9 Stainless Steel
Most stainless steel contains about 18% chromate, but this can be as high as 30%. A thin layer of chromium oxide is formed under conditions of acidity and high chloride content. The oxide film may break down and permit corrosion to occur. Corrosion products are trivalent, but with an oxidizing agent present, hexavalent chromium could be produced. The literature on leaching of chromium from various cooking utensils has been reviewed (Kanerva 1997). It has been concluded that chromium is leached only in small amounts, from stainless steel in contact with marked acidity and high temperature. It is unlikely, that the amount leached from stainless steel utensils – even with acidic food – would exceed 50 μg/day, the amount considered to be beneficial to health. A similar observation was made when the difference in nickel and chromium content was studied in 11 habitual menus cooked in different grades of stainless steel utensils (Accominotti et al. 1998).
5.10 Bleaches and Detergents
A large percentage of female patients tested positive to chromate on routine patch testing, without any obvious cause. A case of a person previously sensitized to dichromate, developing inflammation of the sweat ducts by dipping the forearm in a solution containing 25 μg/mL of chromate for 30 min, has been reported (Nethercott et al. 1996). Allenby and Goodwin (1983) found one patient who reacted to as little as 1 ppm and could not rule out detergents as a factor in chromate dermatitis. A study done on various commonly used detergents in India showed chromate levels (by diphenyl carbazide spot test) to be less than 10 ppm, indicating that chromium may not be an important cause of dermatitis (Krupashankar et al. 2009). Note that the spot test may, because of its detection limits, have missed small amounts of chromate. In Israel, it was found that 90% of detergents and bleaches contained chromium levels higher than 1 ppm, thus resulting in a high incidence of chromium allergy (Ingber et al. 1998). Therefore, to prevent the development of chromium allergy and to decrease the incidence of chromium dermatitis in already sensitized individuals, it is now recommended that the chromium content of household products should not normally exceed 1 ppm (Basketter et al. 2003).
It has been suggested that contact with ashes in cigarette trays could be an explanation of some cases of chromate allergy in females (Clemmensen et al. 1981). The ashes contain a relatively high amount of chromate, and the cloth used to wipe these (by cleaners) would contain increasing concentrations of chromate as the day went on.
5.11 Other Sources of Contact Dermatitis
-
Magnetic tapes (Krook et al. 1977)
-
Paper pulp manufacture (Pirila and Kilpi 1954; Conner 1972; Fregert et al. 1972)
-
Cutting fluids (Calnan 1978a)
-
Tire fitters (Burrows 1981)
-
Food laboratories (Pedersen 1977)
-
Machine oils (Oleffe et al. 1971; Einarsson et al. 1975; Calnan 1978b)
-
Pigment in soap (Mathias 1982)
-
Resin hardeners containing high amounts of chromate (this is especially seen in aircraft workers) (Handley and Burrows 1994)
-
Antifreeze (Freeman 1995)
6 Detection of Chromate
Chromate is often a hidden allergen, and in any situation where a patient has a positive patch test to chromate and has contact dermatitis, one should always suspect the possibility of contact with chromate; spot testing for chromate can be helpful.
6.1 Spot Test for Detection of Hexavalent Chromium (Chromate)
Reagents:
-
(a)
Reagent I: 1,5–diphenylcarbazide (1% wt./vol. in ethanol)
-
(b)
Concentrated sulfuric acid
Investigative procedures:
-
Chromate on the surface of a solid object: A few drops of each reagent are applied on a cotton swab. The cotton swab is thereafter rubbed against the surface of the object for 1 min. If chromate is present, a red-violet color appears.
-
Chromate in solutions: To a sample of approximately 10 mL a few drops of each reagent is added. If chromate is present, a red-violet color appears.
-
Chromate in powders insoluble in water (cement): Cement is mixed with 10 mL water for some minutes. The mixture is then filtered and the filtrate is handled in the same way as described for chromate in solutions.
Reagent I must be prepared immediately before the investigation. Spot testing is not so accurate or easily carried out as the dimethylglyoxime test for nickel.
6.2 Acid Wipe Sampling
This technique detects the presence/amount of nickel, chromium, and cobalt in the skin of workers at their workplace. It is performed by an inductively coupled plasma mass spectrometer and has a high sampling efficiency (Liden et al. 2008).
7 Photosensitivity and Chrome Allergy
Photosensitivity has been suggested as a factor in chrome allergy, since many patients develop dermatitis on the exposed areas. This might be expected in a substance that is a potential airborne allergen (El Sayed and Bazex 1994). However, negligible amounts of chromate were found, in the atmosphere of a Singapore cement construction factory and a busy city center (Goh et al. 1986a). Patients have developed a more intense reaction when sites were irradiated with short-wavelength ultraviolet light (Wahlberg and Wennersten 1977), and recently, both immediate and delayed reactions on patch testing were noted, when subsequently irradiated with ultraviolet light (Manciet et al. 1995). However, White and Rycroft (personal communication) were unable to find an increased incidence of chromate sensitivity in patients with photosensitivity. Even though one can find a certain element of photosensitivity, this is unusual and rare.
8 Effect of Systemic Chromium
Chromium is an essential element, especially in glucose metabolism; and the daily addition of 200 mcg chromium to diet improved the metabolism of glucose in diabetics. It was found that 63% of patients with type 2 diabetes mellitus responded to treatment with chromium as compared to 30% with placebo (Wang et al. 2007). This was substantiated by Ghosh et al. who stipulated that the effect of chromium may be due to an increase in insulin action, rather than stimulation of insulin secretion (Ghosh et al. 2002).
However, a randomized double-blind placebo-controlled study in Netherlands did not find any relation between chromium administration and glycemic control (Kleefstra et al. 2007).
There have been several open studies on the systemic effects of chromate in patients with chromate dermatitis (Schleiff 1968) suggesting an association. Joensen et al. (1979) found that 11 out of 31 patients experienced a flare with 2.5 mg potassium dichromate. Veien et al. (1994), in a placebo-controlled oral challenge of 2.5 mg, found a significant number of flares. McMillen (1990), however, found no connection.
Chromium has been found to induce lipid peroxidation in humans, the precise mechanism of which is not known (Bagchi et al. 1995; Kasprzak 1995). Increased concentrations of chromium and malondialdehyde (product of lipid peroxidation) have been observed, in chromium-exposed workers. Therefore, malondialdehyde may be used as a biomarker for occupational chromium exposure (Huang et al. 1999).
Excessive chromium intake or contact has also been associated with nephrotoxicity (Zhang and Jin 2006).
The daily human chromium intake varies in different geographical areas, and is usually between 20 μg and 85 μg per day, although values up to “130 μg” per day have been reported (Kanerva 1997). In other studies from the USA, the daily dietary intake of chromium was estimated to be 5 μg and 100 μg per day (Kumpulainen et al. 1979; Anderson and Kozlovsky 1985). The doses used in these trials of oral aggravation of chromate dermatitis, therefore, bear no resemblance to anything one might meet in everyday life (even in exceptional circumstances), and do not offer any evidence that chromate dermatitis is aggravated by oral intake. While it is well recognized that nickel and cobalt implants can aggravate dermatitis, particularly in the vicinity of the implant, this does not appear to be a problem with chromium.
9 Prognosis
It is well documented that the prognosis in chromium dermatitis is probably worse than in any other form of dermatitis. A very small percentage was found to be clear after 10–15 years (Burrows 1972). This was later confirmed (Halbert et al. 1992), and a review of the prognosis of occupational hand dermatitis further highlighted the finding (Hogan et al. 1990). Outcome studies were performed before current understanding of exposure, protection, and therapeutics. In the authors’ experience, at least in San Francisco, many workers have a good outcome.
10 Change of Occupation
Data pertaining to the benefits of a change in occupation are unclear, but common wisdom and clinical experience suggest that it would be beneficial. In a review of chromate allergy in 122 patients, followed up for 6–9 years, it was found that 62 (52%) continued in the same occupation and, of these, 55 (89%) had ongoing dermatitis and 7 (11%) had completely cleared despite continuing chromate exposure. The remaining 58 (48%) had completely changed their type of work since initial presentation and, despite this change dermatitis persisted in 40 (69%) workers. The period an individual continued in employment (with dermatitis) prior to change of occupation appeared to be a significant factor in improvement (Halbert et al. 1992).
11 Management
11.1 Prevention
Reduction of exposure is clearly the best method of prevention. Mechanization in the construction industry and allergen replacement, for instance, change to trivalent chromate for plating results in significant improvement (Burrows and Cooke 1980). A survey of the chrome industry reflected the need and scope for further considerable improvement, and efforts to improve hygiene have been worthwhile (Dornan 1981). In a study conducted at an electroplating facility, significant neglect of preventive measures was noted; workers wore internally contaminated gloves, de-gloved themselves in a manner which led to contamination of skin, did not wear personal protective equipment, and displayed unsafe habits (nose-picking) (Cohen et al. 1974).
Hence, employee education regarding high standards of personal hygiene accompanied by the presence of a “responsible person” trained in identifying and reporting any abnormal signs and symptoms among workers are important steps in preventing morbidity (Williams 1998). In addition, proper environmental control of chromic acid mists also needs to be taken into consideration.
Replacing Cr(III) with Cr(VI) in cement is underway in four countries (Norway, Sweden, Finland, and Denmark), which has led to a significant reduction in chromate dermatitis in the cement industry (Bock et al. 2003).
The universal adoption of this practice is hindered by:
-
1.
The decreasing incidence of chromate allergy in the cement industry worldwide (irrespective of the addition of ferrous sulfate).
-
2.
The cost of this preventative measures, which may be considered prohibitive by some. The cost of ferrous sulfate is £150/t/works for bag material; taking into account transport costs and possible price reduction for bulk orders, one could assume a delivered price of £150. The maximum effective level is likely to be 0.5% and, in some circumstances, would need to be 1%. For an annual cement production of 14 million tons in Britain, the additional cost would thus be between £10.5 million and £21 million. There would also be a capital cost of approximately £150,000 for each works. In the UK, there are 19 works, with a capital cost of three million pounds.
-
3.
The change in refractory materials (Tandon and Aarts 1993) and raw materials (Goh and Gan 1996) used, which will anyway lead to a decrease in the amount of chromate in cement. Cement dermatitis is also reviewed elsewhere.
-
4.
The use of dedicated rotary machinery for large-scale mixing, in many countries, thus decreasing skin exposure.
11.2 Barrier Creams and Protective Gloves
It is doubtful that ordinary barrier creams will provide any protective effect. Specific barrier creams that change hexavalent chrome into trivalent chrome have been suggested, including ascorbic acid (Valsecchi and Cainelia 1984), ascorbic acid with ethylenediamine tetra-acetic acid (Romaguera et al. 1985), dithionate (Wall 1982), tartaric acid plus glycine (Romaguera et al. 1985), and sodium metabisulfite (Burrows and Calnan 1965). Romaguera has also found a preparation containing silicone, glyceryl lactate, glycine, and tartaric acid to be effective in a clinical trial. A polymer resin with a chelating agent was found effective in suppressing nickel patch tests positivity (Niklasson et al. 1996). This is also effective in chelating chromate (Niklasson, personal communication). The utility of good protective gloves (Boman 2004) made of proper rubber must not be underestimated.
11.3 Treatment
One of the most important steps in improving prognosis is to isolate the patient from the source as soon as possible (Halbert et al. 1992). A discussion must take place with the patient, because improvement of their dermatitis cannot be guaranteed, and many patients will continue to experience discomfort even though they have no obvious further contact with chromate. Although a satisfactory explanation does not exist, the prolonged persistence in skin or the requirement of only minute quantities of chromate (as found in soil, paper, etc.) might account for the continuing dermatitis. Nevertheless, it is ideal, that the patient be relocated to another area of the company, where there is no exposure to chromate-containing compounds. Otherwise, treatment options remain the same, as for any other eczematous condition; emollients and use of topical steroids, when necessary.
References
Accominotti M, Bost M, Haudrechy P et al (1998) Contribution to chromium and nickel enrichment during cooking of foods in stainless steel utensils. Contact Dermat 38(6):305–310
Allenby CF, Goodwin BF (1983) Influence of detergent washing powders on minimal eliciting patch test concentration of nickel and chromium. Contact Dermat 9(6):491–499
Anderson RA, Kozlovsky AS (1985) Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am J Clin Nutr 41:1177–1183
Athavale P, Shum KW, Chen Y, Agius R, Cherry N, Gawkrodger DJ (2007) Occupational dermatitis related to chromium and cobalt: experience of dermatologists (EPIDERM) and occupational physicians (OPRA) in the U.K. over an 11-year period (1993–2004). Br J Dermatol 157:518–522
Bagchi D, Hassoun EA, Bagchi M, Stohs SJ (1995) Chromium-induced excretion of urinary lipid metabolites, DNA damage, nitric oxide production, and generation of reactive oxygen species in Sprague-Dawley rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 110:177–187
Basketter DA, Angelini G, Ingber A, Kern PS, Menne T (2003) Nickel, chromium and cobalt in consumer products: revisiting safe levels in the new millennium. Contact Dermat 49:1–7
Bidstrup PL (1983) Effects of chrome compounds on the respiratory system. In: Burrows D (ed) Chromium: metabolism and toxicity. CRC, Boca Raton, pp 31–51
Bock M, Schmidt A, Bruckner T, Diepgen TL (2003) Developments in chromate allergy in the German construction industry. Hautarzt 55:460–464
Boman A, Estlander T, Wahlberg JE (2004) Protective gloves for occupational use, 2nd edn. CRC, Boca Raton
Burrows D (1972) Prognosis in industrial dermatitis. Br J Dermatol 87:145–148
Burrows D (1978) Chromium and the skin. Br J Dermatol 99:587–595
Burrows D (1981) Chromium dermatitis in a tyre fitter. Contact Dermat 7:55–56
Burrows D (1983) Chromium: metabolism and toxicity. CRC, Boca Raton
Burrows D (1987) Comparison of 0.25 and 0.5% potassium dichromate in patch testing. Bull Dermatol Allerg Prof 2:117–120
Burrows D, Adams RM (1990) In: Adams RM (ed) Occupational skin disease, 2nd edn. W.B. Saunders, Philadelphia, pp 349–386
Burrows D, Calnan CD (1965) Cement dermatitis. Trans St Johns Hosp Dermatol Soc 51:27–39
Burrows D, Cooke MD (1980) Trivalent chrome plating. Contact Dermat 6:222
Burrows D, Andersen KE, Camaras JG et al (1989) Trial of 0.5% versus 0.3750% potassium dichromate. Contact Dermat 21:351
Calnan CD (1978a) Chromate dermatitis from soluble oil. Contact Dermat 4:378
Calnan CD (1978b) Chromate in coolant water of gramophone record presses. Contact Dermat 4:246–247
Chou TC, Chang HY, Chen CJ, Yu HS, Wu JD, Sheu SC, Shih TS (2008) Effect of hand dermatitis on the total body burden of chromium after ferrous sulfate application in cement among cement workers. Contact Dermat 59:151–156
Clemmensen OJ, Jorgensen J, Jons O et al (1981) Exposure to chromium from hospital cleaning. Derm Beruf Umwelt 3:31–54
Cohen SR, Davis DM, Kramkowski PE (1974) Clinical manifestations of chromic acid toxicity: nasal lesions in electroplate workers. Cutis 13:558–568
Conde-Salazar L, Guimaraens D, Villegas C et al (1995) Occupational allergic contact dermatitis in construction workers. Contact Dermat 33:226–230
Conner B (1972) Chromate dermatitis and paper manufacture. Contact Dermat Newsl 11:265
Decaestecker AM, Marez T, Jdaini J et al (1990) Hypersensitivity to dichromate among asymptomatic workers in a chromate pigment factory. Contact Dermat 23:52–53
Dornan JD (1981) Occupational dermatoses amongst chrome platers in the Sheffield area 1977–80. Contact Dermat 7:354–355
Einarsson O, Kylin B, Lindstedt G et al (1975) Chromium and cobalt in nickel in using cutting fluids. Contact Dermat 1:182–183
El Sayed F, Bazex J (1994) Air-borne contact dermatitis from chromate in cement with recall dermatitis on patch testing. Contact Dermat 30:58
Ellis V, Freeman S (1986) Dermatitis due to chromate in cement. Part 1. Chromate content in cement in Australia. Aust J Dermatol 27:86–90
Fernandez-Nieto M, Quirce S, Carnes J et al (2006) Occupational asthma due to chromium and nickel salts. Int Arch Occup Environ Health 79(6):483–486
Fischer T, Rystedt I (1985) False-positive follicular and irritant patch test reactions to metal salts. Contact Dermat 12:93–98
Freeman S (1995) Chromate allergy from ‘antifreeze-antiboil’. Australas J Dermatol 36:168
Fregert S, Ovrum P (1963) Chromate in welding fumes with special reference to contact dermatitis. Acta Derm Venereol 43:119–124
Fregert S, Gruvberger B, Heijer A (1972) Sensitization to chromium and cobalt in processing of sulfate pulp. Acta Derm Venereol 52:221–224
Fregert S, Gruvberger B, Sandahl E (1979) Reduction of chromate in cement by iron sulfate. Contact Dermat 5:39–42
Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, Chowdhury S (2002) Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem 13:690–697
Goh CL, Gan SL (1996) Changes in cement manufacturing process, a cause for decline in chromate allergy? Contact Dermat 34:51–54
Goh CL, Gan SL, Ngui SJ (1986a) Occupational dermatitis in a prefabrication construction factory. Contact Dermat 15:235–240
Goh CL, Wong PH, Kwok SF et al (1986b) Chromate allergy: total chromium and hexavalent chromium in the air. Derm Beruf Umwelt 34:132–134
Halbert AR, Gebaver KA, Wall LM (1992) Prognosis of occupational chromate dermatitis. Contact Dermat 27:214–219
Handley J, Burrows D (1994) Dermatitis from hexavalent chromate in the accelerator of an epoxy sealant (PT 1422) used in the aircraft industry. Contact Dermat 30:193–196
Hansen MB, Rydin S, Menne T, Duus Johansen J (2002) Quantitative aspects of contact allergy to chromium and exposure to chrome-tanned leather. Contact Dermat 47:127–134
Hogan DJ, Dannaker W, Lal S et al (1990) An international survey of the prognosis of occupational contact dermatitis of the hands. Derm Beruf Umwelt 38:143–147
Huang YL, Chen CY, Sheu JY, Chuang IC, Pan JH, Lin TH (1999) Lipid peroxidation in workers exposed to hexavalent chromium. J Toxicol Environ Health A 56:235–247
Huriez C, Martin P, Lefebvre M (1975) Sensitivity dichromate in a milk analysis laboratory. Contact Dermat 1:247–248
Ingber A, Gammelgaard B, David M (1998) Detergents and bleaches are sources of chromium contact dermatitis in Israel. Contact Dermat 38:101–104
Joensen HD, Thormann J, Jespersen NP et al (1979) Kromallergi medicinsice og sociale aspekter. Ugeskr Laeger 141:1405–1407
Kanerva L (1997) Dermatotoxicological aspects of metallic chromium. Eur J Dermatol 7:79–84
Kanerva L, Jolanki R, Estlander T, Alanko K, Savela A (2000) Incidence rates of occupational allergic contact dermatitis caused by metals. Am J Contact Dermat 11:155–160
Kasprzak KS (1995) Possible role of oxidative damage in metal-induced carcinogenesis. Cancer Invest 13:411–430
Kleefstra N, Houweling ST, Bakker SJ, Verhoeven S, Gans RO, Meyboom-de Jong B, Bilo HJ (2007) Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial. Diab Care 30:1092–1096
Krook G, Fregert S, Gruvberger B (1977) Chromate and cobalt eczema due to magnetic tapes. Contact Dermat 3:60–61
Krupashankar DS, Manjushree D, Rathna MS (2009) Absence of chromates in detergents in India confirmed by diphenyl carbazide spot test. Dermatitis 20:351–352
Kumpulainen JT, Wolf WR, Veillon C, Mertz W (1979) Determination of chromium in selected United States diets. J Agric Food Chem 27:490–494
Kuo HW, Wu ML (2002) Effects of chromic acid exposure on immunological parameters among electroplating workers. Int Arch Occup Environ Health 75(3):186–190
Langard S (1983) The carcinogenicity of chrome compounds in man and animals. In: Burrows D (ed) Chromium: metabolism and toxicity. CRC, Boca Raton, pp 13–31
Lee HS, Goh CL (1988) Occupational dermatitis among chrome platers. Contact Dermat 18:89–93
Liden C, Skare L, Nise G, Vahter M (2008) Deposition of nickel, chromium, and cobalt on the skin in some occupations - assessment by acid wipe sampling. Contact Dermat 58:347–354
Love G (1983) Chromium - biological and analytical considerations. In: Burrows D (ed) Chromium: metabolism and toxicity, edn. CRC, Boca Raton, pp 1–12
Manciet JR, Barrade A, Janssen F, Morel P (1995) Contact allergy with immediate and delayed photoaggravation to chromate and cobalt. Contact Dermat 33:282–284
Mathias CGT (1982) Pigmented cosmetic dermatitis from contact allergy to a toilet soap containing chromium. Contact Dermat 8:29–31
Mignini F, Streccioni V, Baldo M, Vitali M, Indraccolo U, Bernacchia G, Cocchioni M (2004) Individual susceptibility to hexavalent chromium of workers of shoe, hide, and leather industries. Immunological pattern of HLA-B8, DR3-positive subjects. Prev Med 39:767–775
Nethercott JR (1982) Results of routine patch testing of 200 patients in Toronto, Canada. Contact Dermat 8:389–395
Nethercott J, Paustenbach D, Adams R, Fowler J, Marks J, Morton C, Taylor J, Horowitz S, Finley B (1994) A study of chromium induced allergic contact dermatitis with 54 volunteers: implications for environmental risk assessment. Occup Environ Med 51:371–380
Nethercott J, Fowler J, Kauffman L et al (1996) Human response to repetitive hexavalent chromium challenge at 25 flg/ml in water. Jadassohn Centenary Congress, London
Niklasson B, Bjorkner B et al (1996) In vivo evaluation of an active barrier cream in nickel contact allergy. Jadassohn Centenary Congress, London
Oleffe J, Roosels D, Vanderkell J et al (1971) Presence due chrome dans I-environment de travail. Derm Beruf Umwelt 19:57
Pedersen NB (1977) Chromate in a food laboratory. Contact Dermat 3:105
Peltonen L, Fraki J (1983) Prevalence of dichromate sensitivity. Contact Dermat 9:190–194
Pirila V, Kilpi O (1954) On occupational dermatoses in Finland: a report of 1752 cases. Acta Derm Venereol 34:395–402
Polak L (1983) Immunology of chromium. In: Burrows D (ed) Chromium: metabolism and toxicity. CRC, Boca Raton, pp 51–136
Rogers S, Burrows D (1975) Contact dermatitis in milk testers. Contact Dermat 1:387–388
Romaguera C, Grimalt F, Vilaplana J, Carreras E (1985) Formulation of a barrier cream against chromate. Contact Dermat 13:49–52
Rudolf E, Cervinka M, Cerman J, Schroterova L (2005) Hexavalent chromium disrupts the actin cytoskeleton and induces mitochondria-dependent apoptosis in human dermal fibroblasts. Toxicol In Vitro 19:713–723
Rycroft UG, Calnan CD (1977) Relapse of chromate dermatitis from sheet metal. Contact Dermat 3:177–180
Schleiff P (1968) Provokation des Chromatekzems zu Testwecken durch interne Chrornzufubr. Hautarzt 19:209–210
Shelley WB (1964) Chromium in welding fumes as cause of eczematous hand eruption. JAMA 189:772–773
Snyder CA, Udasin I, Waterman SJ et al (1996) Reduced IL-6 levels among individuals in Hudson County, New Jersey, an area contaminated with chromium. Arch Environ Health 51:26–28
Tandon R, Aarts B (1993) Chromium, nickel and cobalt contents of some Australian cements. Contact Dermat 28:201–205
Thyssen JP, Jensen P, Carlsen BC, Engkilde K, Menne T, Johansen JD (2009) The prevalence of chromium allergy in Denmark is currently increasing as a result of leather exposure. Br J Dermatol 161:1288–1293
Valsecchi R, Cainelia T (1984) Chromium dermatitis and ascorbic acid. Contact Dermat 10:252–253
Veien NK, Hattel T, Laurberg G (1994) Chromate-allergic patients challenged orally with potassium dichromate. Contact Dermat 31:137–139
Wahlberg JE, Wennersten G (1977) Light sensitivity and chromium dermatitis. Br J Dermatol 97:411–416
Wall LM (1982) Chromate dermatitis and sodium dithionite. Contact Dermat 8:291–293
Walsh EN (1953) Chromate hazards in industry. J Am Med Assoc 153:1305–1308
Wang ZQ, Qin J, Martin J, Zhang XH, Sereda O, Anderson RA, Pinsonat P, Cefalu WT (2007) Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. Metabolism 56:1652–1655
Williams N (1997) Occupational skin ulceration in chrome platers. Occup Med Lond 47:309–310
Williams N (1998) Nasal septal ulceration and perforation in jiggers. Occup Med Lond 48:135–137
Zhang GS, Jin YL (2006) Studies on the nephrotoxicity of chromium compounds. Wei Sheng Yan Jiu 35:659–662
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Sethi, G., Belum, V.R., Burrows, D., Maibach, H.I., Hostynek, J.J. (2012). Chromium. In: Rustemeyer, T., Elsner, P., John, SM., Maibach, H.I. (eds) Kanerva's Occupational Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02035-3_44
Download citation
DOI: https://doi.org/10.1007/978-3-642-02035-3_44
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02034-6
Online ISBN: 978-3-642-02035-3
eBook Packages: MedicineReference Module Medicine